BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Policy

  GeneLink, Inc. Reports Denial of Appeal

  April 5, 2011

   · 

  1 min read
• Drug Development

  Neurocrine Biosciences, Inc. Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor

  April 5, 2011

   · 

  5 min read
• FDA to Address Industry Questions About Biosimilar Regulations at the Pharma IQ’s Immunogenicity Event

  April 5, 2011

   · 

  2 min read
• Drug Development

  Tolerx, Inc. Presents Preclinical Data on Novel Anti-GITR Cancer Immunotherapeutic Demonstrating Enhanced Anti-Tumor Responses

  April 5, 2011

   · 

  3 min read
• Business

  Par Pharmaceutical Companies, Inc. to Report First Quarter 2011 Results on May 5, 2011

  April 5, 2011

   · 

  1 min read
• Deals

  Royalty Pharma Acquires Lexiscan(R) and Cubicin(R) Royalties for $487 Million

  April 5, 2011

   · 

  2 min read
• Genetown

  Astra Tech AB Launches Atlantis(TM) interface – for Keystone Dental PrimaConnex(TM)

  April 5, 2011

   · 

  1 min read
• BioCapital

  Novavax, Inc.'s VLP Influenza Vaccine Named One of Top 100 Drugs in Development Today

  April 5, 2011

   · 

  2 min read
• Drug Development

  Keryx Biopharmaceuticals Announces Results on KRX-0401 (Perifosine) at American Association for Cancer Research Annual Meeting

  April 5, 2011

   · 

  5 min read
• Business

  BioLeap Enters into Research Collaboration with Syngenta on Molecular Design of Crop Protection Products

  April 5, 2011

   · 

  1 min read